Janus Henderson Group PLC Novo Cure LTD Transaction History

Janus Henderson Group PLC

$194 Billion
Q2 2025

A detailed history of Janus Henderson Group PLC transactions in Novo Cure LTD stock. As of the latest transaction made, Janus Henderson Group PLC holds 45,000 shares of NVCR stock, worth $576,450. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,000

Previous 45,000 -0.0%

Holding current value

$576,450

Previous $801,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$17.82 - $30.19 $92,664 - $156,988	-5,200 Reduced 10.36%	45,000 $801,000
Q2 2024 Aug 14, 2024	SELL	$11.83 - $24.05 $120,666 - $245,310	-10,200 Reduced 16.89%	50,200 $859,000
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $24 - $34	2 Added 0.0%	60,400 $944,000
Q4 2023 Feb 14, 2024	SELL	$11.13 - $15.78 $1,391 - $1,972	-125 Reduced 0.21%	60,398 $901,000
Q3 2023 Nov 14, 2023	BUY	$16.15 - $42.35 $806,611 - $2.12 Million	49,945 Added 472.16%	60,523 $977,000
Q2 2023 Aug 14, 2023	SELL	$40.29 - $82.51 $46,978 - $96,206	-1,166 Reduced 9.93%	10,578 $438,000
Q1 2023 May 15, 2023	SELL	$56.44 - $118.81 $829,724 - $1.75 Million	-14,701 Reduced 55.59%	11,744 $706,000
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $983,436 - $1.31 Million	15,371 Added 138.8%	26,445 $1.94 Million
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $129,180 - $170,183	-1,900 Reduced 14.64%	11,074 $841,000
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $69,165 - $109,857	-1,222 Reduced 8.61%	12,974 $902,000
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $363,125 - $510,247	-6,037 Reduced 29.84%	14,196 $1.18 Million
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $2.71 Million - $4.41 Million	-36,134 Reduced 64.1%	20,233 $1.52 Million
Q3 2021 Nov 16, 2021	BUY	$116.17 - $194.55 $3.09 Million - $5.18 Million	26,625 Added 89.52%	56,367 $6.55 Million
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $2.55 Million - $4.4 Million	-19,519 Reduced 39.62%	29,742 $6.6 Million
Q1 2021 May 17, 2021	BUY	$124.11 - $190.17 $5.42 Million - $8.3 Million	43,647 Added 777.47%	49,261 $6.51 Million
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $629,666 - $977,621	5,614 New	5,614 $969,000

Others Institutions Holding NVCR

# of Institutions

283

Shares Held

76.7M

Call Options Held

943K

Put Options Held

155K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.34B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Novo Cure LTD Transaction History